Overview
Provides full range of oncology clinical-trials services, from phase I to phase IV
400+ employees involved in drug development
More than 165 locations staffed for research
260+ studies completed to date
3,200 accrued patients in 2002 and estimated 3,300 patients accrued for research studies in 2003
Provided clinical trial access to more than 21,000 patients in the last nine years
US Oncology has played an important role in bringing 12 new drugs to market.